This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fisher, L. W. Articles by Fedarko, N. S. Search for Related Content PubMed PubMed Citation Articles by Fisher, L. W. Articles by Fedarko, N. S.

Small Integrin Binding Ligand N-Linked Glycoprotein Gene Family Expression in Different Cancers

¹ Craniofacial and Skeletal Diseases Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland; and ² Division of Geriatric Medicine, Department of Medicine, Johns Hopkins University, Baltimore, Maryland

Purpose: Members of the small integrin binding ligand N-linked glycoprotein (SIBLING) gene family have the capacity to bind and modulate the activity of matrix metalloproteinases (MMPs). The expression levels of five SIBLING gene family members [bone sialoprotein (BSP), osteopontin (OPN), dentin matrix protein 1 (DMP1), matrix extracellular phosphoglycoprotein (MEPE), and dentin sialophosphoprotein (DSPP)] and certain MMPs were determined using a commercial cancer array.

Experimental Design: Cancer profiling arrays containing normalized cDNA from both tumor and corresponding normal tissues from 241 individual patients were used to screen for SIBLING and MMP expression in nine distinct cancer types.

Results: Significantly elevated expression levels were observed for BSP in cancer of the breast, colon, stomach, rectum, thyroid, and kidney; OPN in cancer of the breast, uterus, colon, ovary, lung, rectum, and thyroid; DMP1 in cancer of the breast, uterus, colon, and lung; and dentin sialophosphoprotein in breast and lung cancer. The degree of correlation between a SIBLING and its partner MMP was found to be significant within a given cancer type (e.g., BSP and MMP-2 in colon cancer, OPN and MMP-3 in ovarian cancer; DMP1 and MMP-9 in lung cancer). The expression levels of SIBLINGs were distinct within subtypes of cancer (e.g., breast ductal tumors compared with lobular tumors). In general, SIBLING expression increased with cancer stage for breast, colon, lung, and rectal cancer.

Conclusions: These results suggest SIBLINGs as potential markers of early disease progression in a number of different cancer types, some of which currently lack vigorous clinical markers.

This article has been cited by other articles:

				C. Qin, R. D'Souza, and J.Q. Feng Dentin Matrix Protein 1 (DMP1): New and Important Roles for Biomineralization and Phosphate Homeostasis J. Dent. Res., December 1, 2007; 86(12): 1134 - 1141. [Abstract] [Full Text] [PDF]

				L. R. Amir, A. Jovanovic, F. B.T. Perdijk, S. Toyosawa, V. Everts, and A. L.J.J. Bronckers Immunolocalization of Sibling and RUNX2 Proteins During Vertical Distraction Osteogenesis in the Human Mandible J. Histochem. Cytochem., November 1, 2007; 55(11): 1095 - 1104. [Abstract] [Full Text] [PDF]

				L. R. Rodrigues, J. A. Teixeira, F. L. Schmitt, M. Paulsson, and H. Lindmark-Mansson The Role of Osteopontin in Tumor Progression and Metastasis in Breast Cancer Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1087 - 1097. [Abstract] [Full Text] [PDF]

				R. B T Verkooijen, J. W A Smit, J. A Romijn, and M. P M Stokkel The incidence of second primary tumors in thyroid cancer patients is increased, but not related to treatment of thyroid cancer Eur. J. Endocrinol., December 1, 2006; 155(6): 801 - 806. [Abstract] [Full Text] [PDF]

				Q. Zhang, K. Furukawa, H.-H. Chen, T. Sakakibara, T. Urano, and K. Furukawa Metastatic Potential of Mouse Lewis Lung Cancer Cells Is Regulated via Ganglioside GM1 by Modulating the Matrix Metalloprotease-9 Localization in Lipid Rafts J. Biol. Chem., June 30, 2006; 281(26): 18145 - 18155. [Abstract] [Full Text] [PDF]

				J.-S. Nam, A. M. Suchar, M.-J. Kang, C. H. Stuelten, B. Tang, A. M. Michalowska, L. W. Fisher, N. S. Fedarko, A. Jain, J. Pinkas, et al. Bone Sialoprotein Mediates the Tumor Cell-Targeted Prometastatic Activity of Transforming Growth Factor {beta} in a Mouse Model of Breast Cancer. Cancer Res., June 15, 2006; 66(12): 6327 - 6335. [Abstract] [Full Text] [PDF]

				A. Karadag, N. S. Fedarko, and L. W. Fisher Dentin Matrix Protein 1 Enhances Invasion Potential of Colon Cancer Cells by Bridging Matrix Metalloproteinase-9 to Integrins and CD44 Cancer Res., December 15, 2005; 65(24): 11545 - 11552. [Abstract] [Full Text] [PDF]